MY173606A - Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease - Google Patents

Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease

Info

Publication number
MY173606A
MY173606A MYPI2017703107A MYPI2017703107A MY173606A MY 173606 A MY173606 A MY 173606A MY PI2017703107 A MYPI2017703107 A MY PI2017703107A MY PI2017703107 A MYPI2017703107 A MY PI2017703107A MY 173606 A MY173606 A MY 173606A
Authority
MY
Malaysia
Prior art keywords
treatment
prophylaxis
dry eye
synthetic peptide
eye disease
Prior art date
Application number
MYPI2017703107A
Inventor
Yeou-Ping Tsao
Tsung-Chuan Ho
Original Assignee
Mackay Memorial Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mackay Memorial Hospital filed Critical Mackay Memorial Hospital
Priority to MYPI2017703107A priority Critical patent/MY173606A/en
Priority claimed from PCT/CN2015/073257 external-priority patent/WO2016134498A1/en
Publication of MY173606A publication Critical patent/MY173606A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Disclosed herein are synthetic peptides and compositions comprising the same for the treatment and/ or prophylaxis of an ocular disease, particularly, dry eye disease. Also disclosed herein are methods of treating and/ or preventing an ocular disease by administering to a subject in need of such treatment a composition containing a synthetic peptide of the present disclosure.
MYPI2017703107A 2015-02-25 2015-02-25 Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease MY173606A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2017703107A MY173606A (en) 2015-02-25 2015-02-25 Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI2017703107A MY173606A (en) 2015-02-25 2015-02-25 Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
PCT/CN2015/073257 WO2016134498A1 (en) 2015-02-25 2015-02-25 Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease

Publications (1)

Publication Number Publication Date
MY173606A true MY173606A (en) 2020-02-10

Family

ID=79877101

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2017703107A MY173606A (en) 2015-02-25 2015-02-25 Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease

Country Status (1)

Country Link
MY (1) MY173606A (en)

Similar Documents

Publication Publication Date Title
MX2016012574A (en) Substituted heteroaryl compounds and methods of use.
EA201790273A1 (en) FLAGELLIN COMPOSITIONS AND THEIR APPLICATION
NZ742018A (en) Injectable botulinum toxin formulations and methods of use thereof having long duration of therapeutic or cosmetic effect
MX2017003211A (en) Anti-met antibodies and compositions.
MX2020004076A (en) Stabilized omega-3 ophthalmic compositions.
WO2015171558A3 (en) BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE
PH12017500098A1 (en) Suspension compositions of cyclosporin a for subconjunctival and periocular injection
PH12017500615A1 (en) Ophthalmic composition comprising cyclosporine and trehalose
MX2022002635A (en) Angiopoietin-like 4 antibodies and methods of use.
MX2017002388A (en) Compositions for keratin fibers.
MY194448A (en) Short synthetic peptide for treating diseases and/or conditions related to angiogenesis
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
PH12021550122A1 (en) Solubilized apyrases, methods and use
MX2016000448A (en) Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage.
MX2018014129A (en) Pharmaceutical composition comprising eteplirsen.
MX2020000636A (en) Synthetic proteins and therapeutic uses thereof.
NZ734845A (en) Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
NZ737410A (en) Compositions comprising anakinra
MX2017003949A (en) Novel peptide derivatives and uses thereof.
MX2019009293A (en) Compounds, compositions and uses thereof for improvement of bone disorders.
GEP20207145B (en) Combination of trazodone and gabapentin for the treatmen
WO2015200768A3 (en) Pharmacologic treatments of menière's disease
MY173606A (en) Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
EA201892389A1 (en) OPHALMOLOGICAL COMPOSITION CONTAINING THE SYNERGISTIC COMBINATION OF GLYCOGEN AND HYALURONIC ACID OR ITS SALT
MX2019004179A (en) Apilimod compositions and methods for using same in the treatment of alzheimer's disease.